Market Place
Sourcing Support
All News #Library
Others
ScinoPharm Taiwan Achieves Zero-Deficiency In ANVISA Inspection
21 Nov 2024 //
PRESS RELEASE
ScinoPharm Taiwan Expands Injectables, CDMO Amid H1 Growth
08 Nov 2024 //
PRESS RELEASE
ScinoPharm reports 36% Q1 revenue growth, passes FDA audit
06 May 2024 //
PRESS RELEASE
ScinoPharm Taiwan shows steady operations, focuses on injectable
15 Mar 2024 //
PRESS RELEASE
Baxter and ScinoPharm sign injectable oncology drug strategic alliance
25 Mar 2020 //
IN-PHARMATECHNOLOGIST
Despite Its High P/E Ratio, Is ScinoPharm Taiwan, Still Undervalued?
18 Mar 2020 //
SIMPLYWALL
ScinoPharm’s Transformation Continues to Yield Results Stable Development in Injection Business
02 Mar 2020 //
PRESS RELEASE
ScinoPharm Reports Financial Performance for 2017
23 Feb 2020 //
PRESS RELEASE
ScinoPharm Announces 2019 H1 Business Report
07 Aug 2019 //
PRESS RELEASE
ScinoPharm Taiwan Announces Annual Financial Report for 2018
01 Apr 2019 //
PRESS RELEASE
ScinoPharm head takes over amid upheaval of market
03 Aug 2018 //
TAIPEITIMES
ScinoPharm expects more trouble from FX, mergers
23 Mar 2018 //
TAIPEITIMES
Baxter, ScinoPharm partner to develop 5 injectable drugs for cancer treatments
01 Mar 2017 //
PHARMABIZ
Notification of ScinoPharm (Changshu) Pharmaceuticals, Ltd. Name Change
12 Dec 2016 //
PRESS RELEASE
ScinoPharm and CVie Therapeutics Limited To Jointly Develop New Heart Failure Drug
05 Aug 2016 //
PRESS RELEASE
ScinoPharm and CVie Therapeutics Limited to Jointly Develop Heart Failure Drug
05 Aug 2016 //
PR NEWSWIRE
Scinopharm of Taiwan denied Indian patent on Anhydrous Docetaxel
25 Feb 2016 //
TWOFOUR INSIGHT
ScinoPharm: expanding scope, more products in pipeline, says CEO
22 Feb 2016 //
IN PHARMATECHNOLOGIST
ScinoPharm Changshu Site Completed US FDA Inspection
12 Nov 2015 //
PR NEWS WIRE
ScinoPharm collaborates with Raffles PharmaTech
23 Jun 2015 //
BIOSPECTRUM ASIA
ScinoPharm to Engage in Strategic Collaboration with Raffles
22 Jun 2015 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.